Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti‐TNF‐α: results from the ENEIDA registry
F Mesonero, J Castro‐Poceiro… - Alimentary …, 2021 - Wiley Online Library
Background Methotrexate can be used to maintain remission in Crohn's disease patients
who are intolerant to thiopurines. Data on its use as monotherapy in other scenarios are …
who are intolerant to thiopurines. Data on its use as monotherapy in other scenarios are …
Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry
F Mesonero, J Castro-Poceiro… - Alimentary …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Methotrexate can be used to maintain remission in Crohn's disease patients
who are intolerant to thiopurines. Data on its use as monotherapy in other scenarios are …
who are intolerant to thiopurines. Data on its use as monotherapy in other scenarios are …
Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti‐TNF‐α: results from the ENEIDA registry.
F Mesonero, J Castro‐Poceiro… - Alimentary …, 2021 - search.ebscohost.com
Background: Methotrexate can be used to maintain remission in Crohn's disease patients
who are intolerant to thiopurines. Data on its use as monotherapy in other scenarios are …
who are intolerant to thiopurines. Data on its use as monotherapy in other scenarios are …
Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry.
F Mesonero, J Castro-Poceiro, JM Benítez… - Alimentary …, 2021 - europepmc.org
Background Methotrexate can be used to maintain remission in Crohn's disease patients
who are intolerant to thiopurines. Data on its use as monotherapy in other scenarios are …
who are intolerant to thiopurines. Data on its use as monotherapy in other scenarios are …